Fred Alger Management’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$403K Buy
2,375
+256
+12% +$41.6K ﹤0.01% 393
2026
Q2
$326K Sell
2,119
-60,455
-97% -$9.27M ﹤0.01% 406
2026
Q1
$10M Sell
62,574
-16,820
-21% -$2.83M 0.04% 168
2025
Q4
$12.7M Buy
+79,394
New +$9.4M 0.05% 156

Other funds holding BLTE

Fred Alger Management's BLTE Position: Q3 2026 in Review

Fred Alger Management increased its Belite Bio (BLTE) stake by 12% in Q3 2026, buying an estimated $41.6K and bringing the position to 2,375 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #393.

Fred Alger Management first reported a position in BLTE in Q4 2025 and has held it in 4 quarters since. The position peaked at $12.7M in Q4 2025. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Fred Alger Management held 2,375 shares of Belite Bio worth $403K as of Q3 2026.
  • Fred Alger Management bought 256 Belite Bio shares in Q3 2026, an estimated $41.6K.
  • Belite Bio made up ﹤0.01% of Fred Alger Management's portfolio in Q3 2026, its #393 holding.
  • Fred Alger Management first reported a position in Belite Bio in Q4 2025 and has held it in 4 quarters since.
  • Fred Alger Management's Belite Bio position peaked at $12.7M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Fred Alger Management's 13F filing for Q3 2026, filed 16 Nov 2026.